Real‐life evaluation of a COVID‐19 rapid antigen detection test in hospitalized children
Open Access
- 1 July 2021
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (10) , 6040-6044
Abstract
Rapid antigen detection (RAD) tests for the detection of SARS‐CoV‐2 are simpler, faster, and less expensive than the reverse‐transcription polymerase chain reaction (RT‐PCR) that is currently considered the gold standard for the diagnosis of coronavirus disease 2019 (COVID‐19). The objective of this study was to determine the performance of the PANBIO COVID‐19 Ag RAD (Abbott) test, a lateral flow immunoassay that detects the nucleocapsid protein, using as a reference RT‐PCR method the Cobas®8800 System (Roche Diagnostics). This prospective study was conducted in a tertiary Children's Hospital and included individuals aged ≤16 years with COVID‐19‐related symptoms or epidemiological criteria for COVID‐19. Two nasopharyngeal samples were collected to perform the PANBIO RAD test and RT‐PCR. Of 744 children included, 51 (6.86%) had a positive RT‐PCR result. The RAD test detected 42 of 51 PCR‐positive children while there were no false‐positive results. The overall sensitivity and specificity were 82.35% (95% CI, 71.9%–92.8%) and 100%, respectively. Sensitivity was >95% in symptomatic children. The assay performed poorly in asymptomatically infected children. In agreement with previous studies in adults, the PANBIO RAD test can be useful in screening for COVID‐19 in children admitted with symptoms suggestive of the disease, especially in the first days of the illness.Keywords
This publication has 13 references indexed in Scilit:
- Diagnostic Accuracy of the Panbio Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Rapid Test Compared with Reverse-Transcriptase Polymerase Chain Reaction Testing of Nasopharyngeal Samples in the Pediatric PopulationThe Journal of Pediatrics, 2021
- Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centresClinical Microbiology and Infection, 2021
- Nasopharyngeal SARS-CoV-2 viral loads in young children do not differ significantly from those in older children and adultsScientific Reports, 2021
- Put to the test: use of rapid testing technologies for covid-19BMJ, 2021
- Nasopharyngeal Panbio COVID-19 Antigen Performed at Point-of-Care Has a High Sensitivity in Symptomatic and Asymptomatic Patients With Higher Risk for Transmission and Older AgeOpen Forum Infectious Diseases, 2021
- Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19Journal of Clinical Microbiology, 2021
- Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital settingMedical Microbiology and Immunology, 2021
- Limits and Opportunities of SARS-CoV-2 Antigen Rapid Tests: An Experienced-Based PerspectivePathogens, 2021
- Rethinking Covid-19 Test Sensitivity — A Strategy for ContainmentNew England Journal of Medicine, 2020
- Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosisJournal of Clinical Virology, 2020